These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7567130)

  • 41. [Endocarditis caused by Moraxella lacunata on the natural and prosthetic valves. An unusual pathogenesis].
    Robles M; Tejada J; Jerez V; Pérez D; Jimeno B; Julia JA
    Enferm Infecc Microbiol Clin; 1998; 16(6):290-1. PubMed ID: 9763750
    [No Abstract]   [Full Text] [Related]  

  • 42. Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes.
    Murashita T; Sugiki H; Kamikubo Y; Yasuda K
    Eur J Cardiothorac Surg; 2004 Dec; 26(6):1104-11. PubMed ID: 15541970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pretreatment with aminophylline reduces release of Troponin I and neutrophil activation in the myocardium of patients undergoing cardioplegic arrest.
    Luo WJ; Qian JF; Jiang HH
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):360-5. PubMed ID: 17188883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ceftriaxone pharmacokinetics during cardiopulmonary bypass.
    Oksenhendler G; Leroy A; Schleifer D; Hubscher C; Soyer R
    Chemioterapia; 1987 Jun; 6(2 Suppl):271-2. PubMed ID: 3509410
    [No Abstract]   [Full Text] [Related]  

  • 45. [Diffusion of ceftriaxone in human bone tissue].
    Soudry B; Sirot J; Lopitaux R; Dumont C; Delisle JJ; Parenton M
    Pathol Biol (Paris); 1986 Sep; 34(7):859-62. PubMed ID: 3537931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ceftriaxone pharmacokinetics in elderly subjects and penetration into epididymis.
    Geny F; Costa P; Bressolle F; Galtier M
    Biopharm Drug Dispos; 1993 Mar; 14(2):161-9. PubMed ID: 8453025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues.
    Martin C; Bourget P; Alaya M; Sertin A; Atlani C; Ennabli K; Said R
    Antimicrob Agents Chemother; 1997 May; 41(5):1150-5. PubMed ID: 9145887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum and tissue concentrations of intravenous ceftriaxone during aortic surgery.
    Robbs JV; Salisbury RT; Elson KI; Brock-Utne JG
    S Afr J Surg; 1989 Sep; Suppl():11-2. PubMed ID: 2799564
    [No Abstract]   [Full Text] [Related]  

  • 49. Concentrations in plasma and tissue penetration of ceftriaxone and ornidazole during liver transplantation.
    Steib A; Jacoberger B; Von Bandel M; Beck F; Beller JP; Boudjema K; Koffel JC; Otteni JC
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1873-6. PubMed ID: 8239599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ceftriaxone is an efficient component of antimicrobial regimens in the prevention and initial management of infections in end-stage renal disease.
    Trimarchi H; Lafuente P; Suki WN
    Am J Nephrol; 2000; 20(5):391-5. PubMed ID: 11092997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Penetration of ceftriaxone into the intervertebral disc.
    Lang R; Folman Y; Ravid M; Bental T; Gepstein R
    J Bone Joint Surg Am; 1994 May; 76(5):689-91. PubMed ID: 8175816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ceftriaxone levels in blood and tissue during cardiopulmonary bypass surgery.
    Bryan CS; Morgan SL; Jordan AB; Smith CW; Sutton JP; Gangemi JD
    Antimicrob Agents Chemother; 1984 Jan; 25(1):37-9. PubMed ID: 6322680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concentrations of prophylactic ceftriaxone in abdominal tissues during pancreatic surgery.
    Martin C; Cottin A; François-Godfroy N; Mallet MN; Martin A; Sastre B; De Micco P; Gouin F
    J Antimicrob Chemother; 1997 Sep; 40(3):445-8. PubMed ID: 9338502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pharmacodynamics of antibiotics in their preventive use in heart surgery with general artificial circulation].
    Krastin OA; Grabar LE; Korchagin VA; Chagorov NV
    Klin Khir (1962); 1990; (10):17-8. PubMed ID: 2280517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone.
    Lovering AM; Walsh TR; Bannister GC; MacGowan AP
    J Antimicrob Chemother; 2001 Apr; 47(4):483-6. PubMed ID: 11266427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of ceftriaxone in serum and in gynecological tissues.
    Götz A; Weissenbacher ER; Gutschow K; Wachter I; Schneider A
    Acta Eur Fertil; 1987; 18(2):127-8. PubMed ID: 3630575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of ceftriaxone in neonatal foals.
    Ringger NC; Brown MP; Kohlepp SJ; Gronwall RR; Merritt K
    Equine Vet J; 1998 Mar; 30(2):163-5. PubMed ID: 9535074
    [No Abstract]   [Full Text] [Related]  

  • 58. Influence of therapeutic plasmapheresis on elimination of ceftiaxone.
    Bakken JS; Cavalieri SJ; Gangeness D; Kubat T; Pollack JR
    Antimicrob Agents Chemother; 1993 May; 37(5):1171-3. PubMed ID: 8517709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ceftriaxone penetration of tissues.
    Billstein SA
    Chemotherapy; 1988; 34 Suppl 1():53-8. PubMed ID: 3073046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Penetration of penicillins into cardiac valves and auricles of patients undergoing open-heart surgery.
    Pieper R; Henze A; Josefsson K; Magni L; Nord CE
    Scand J Thorac Cardiovasc Surg; 1985; 19(1):49-53. PubMed ID: 4012241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.